STRS Ohio’s Avita Medical RCEL Stock Holding History

STRS Ohio’s Portfolio RCEL Stock Details RCEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$176K	Hold	47,700	–	–	﹤0.01%	1552
2025 Q4	$165K	Hold	47,700	–	–	﹤0.01%	1611
2025 Q3	$244K	Buy	47,700 +33,400	+234%	+$174K	﹤0.01%	1441
2025 Q2	$75.6K	Hold	14,300	–	–	﹤0.01%	1945
2025 Q1	$116K	Hold	14,300	–	–	﹤0.01%	1638
2024 Q4	$183K	Hold	14,300	–	–	﹤0.01%	1532
2024 Q3	$153K	Hold	14,300	–	–	﹤0.01%	1630
2024 Q2	$113K	Sell	14,300 -17,300	-55%	-$165K	﹤0.01%	1676
2024 Q1	$506K	Sell	31,600 -9,500	-23%	-$154K	﹤0.01%	1254
2023 Q4	$563K	Buy	41,100 +4,200	+11%	+$48.1K	﹤0.01%	1216
2023 Q3	$539K	Buy	36,900 +900	+3%	+$15.2K	﹤0.01%	1217
2023 Q2	$612K	Buy	+36,000	New	+$528K	﹤0.01%	1166
2022 Q2	–	Sell	-5,500	Closed	-$46K	–	2241
2022 Q1	$46K	Hold	5,500	–	–	﹤0.01%	1955
2021 Q4	$65K	Hold	5,500	–	–	﹤0.01%	1966
2021 Q3	$97K	Hold	5,500	–	–	﹤0.01%	1947
2021 Q2	$112K	Buy	+5,500	New	+$108K	﹤0.01%	1951

Other funds holding RCEL

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

STRS Ohio's RCEL Position: Q1 2026 in Review

STRS Ohio held its Avita Medical (RCEL) position steady in Q1 2026 at 47,700 shares worth $176K. The position accounts for ﹤0.01% of the portfolio, ranked #1552.

STRS Ohio first reported a position in RCEL in Q2 2021 and has held it in 16 quarters since. The position peaked at $612K in Q2 2023. 79 funds tracked by Wall St. Rank hold RCEL as of Q1 2026.

STRS Ohio held 47,700 shares of Avita Medical worth $176K as of Q1 2026.
STRS Ohio left its Avita Medical share count unchanged in Q1 2026.
Avita Medical made up ﹤0.01% of STRS Ohio's portfolio in Q1 2026, its #1552 holding.
STRS Ohio first reported a position in Avita Medical in Q2 2021 and has held it in 16 quarters since.
STRS Ohio's Avita Medical position peaked at $612K in Q2 2023.
79 funds tracked by Wall St. Rank held Avita Medical as of Q1 2026.

Based on STRS Ohio's 13F filing for Q1 2026, filed 24 Apr 2026.